The U.S. Food and Drug Administration (FDA) has granted approval for Atomoxetine HCl--a generic version of the ADHD medication Strattera. The FDA approved the drugmaker’s capsules in the 10mg, 18mg, 25mg, 40mg, 60mg, 80mg and 100mg strengths. No release date has been set, pending a U.S. Court of Appeals decision about Strattera's patent.
This question has been on my mind lately after my son’s neurologist recommended a name-brand medication to treat his seizures instead of... Read more »
Reader's Question: I have been told that Fosamax is coming out in generic form. I have been taking a brand name osteoporosis drug (in the... Read more »
There is a fascinating, if a bit troubling, controversy going on in England over osteoporosis drugs. Doctors and patients alike -- more... Read more »
Recently, a question was asked by one reader as to whether a generic form of an erectile dysfunction medication is different than the... Read more »
It's been seven weeks since I had my baby. The time is really flying by and soon my maternity leave will be over. I've been slowly... Read more »
Drugmaker Ethex Corporation is recalling dozens of drugs, including generic formulas of OxyContin, Toprol XL, and Norvasc, because of potential... Read more »
The Indian drug company Dr Reddy's Laboratories Ltd says that the U.S. Food and Drug Administration has approved a generic, over-the-counter version... Read more »
Officials at the Federal Trade Commission (FTC) say the 12- to 14-year patent-protection period given to biologic medications is too long to "promote... Read more »
According to generic drugmaker Mylan, the U.S. Food and Drug Administration (FDA) has approved their generic version of the migraine med Imitrex. The... Read more »
Drugmaker Valeant Pharma has announced that it has begun selling a generic version of Librax, a drug used to treat irritable bowel syndrome. Librax... Read more »